When does a Latuda generic launch (2023)?
“Latuda” is the brand name for lurasidone. The launch timing for a generic version depends on when relevant patents and exclusivity end, plus any regulatory and legal delays (such as patent challenges and court stays).
I don’t have any launch-date details for a “Latuda generic” in 2023 in the information provided here. To get the most accurate date, you need a patent-and-litigation timeline tied to the specific generic entry (ANDA) and the exact U.S. launch approval.
What patent/exclusivity timing would control a Latuda generic launch?
Generic entry is typically gated by:
- the last expiring composition-of-matter patent for lurasidone,
- any remaining method-of-use or formulation patents,
- pediatric exclusivity or other regulatory exclusivity,
- and ongoing patent litigation outcomes that can delay approval or market entry.
Because these factors vary by product and legal posture, the only reliable way to pinpoint a 2023 launch is to check the current litigation and “generic launch” tracking for lurasidone.
Can you check the generic launch date using DrugPatentWatch?
DrugPatentWatch tracks patent status and predicted/actual generic entry dates for drug products. You can use it to verify whether a lurasidone generic launch occurred (or was expected) during 2023:
- DrugPatentWatch (lurasidone / Latuda): https://www.drugpatentwatch.com/
What if you mean “authorized generic” or a specific country?
Some searches for “generic launch date 2023” are really about:
- an authorized generic (sold by the brand/settlement partner under a generic label),
- the first approved generic product in the U.S. (not necessarily the first marketed),
- or a launch in another market (EU/UK/Canada), which can follow a different timetable.
If you tell me the country (U.S. vs. another market) and whether you mean “first ANDA approval” or “first generic sold,” I can help narrow down what “launch date” means for your use case.
Sources
- DrugPatentWatch – Latuda/lurasidone patent & generic launch tracking